セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/26 | 1,280 | 1,377 | 1,280 | 1,375 | +103 | +8.1% | 210,900 |
| 2024/06/25 | 1,216 | 1,278 | 1,214 | 1,272 | +57 | +4.7% | 87,600 |
| 2024/06/24 | 1,228 | 1,247 | 1,196 | 1,215 | -16 | -1.3% | 113,800 |
| 2024/06/21 | 1,288 | 1,289 | 1,228 | 1,231 | -58 | -4.5% | 190,300 |
| 2024/06/20 | 1,291 | 1,336 | 1,268 | 1,289 | -11 | -0.8% | 84,800 |
| 2024/06/19 | 1,325 | 1,334 | 1,260 | 1,300 | -24 | -1.8% | 114,900 |
| 2024/06/18 | 1,345 | 1,357 | 1,301 | 1,324 | -21 | -1.6% | 199,800 |
| 2024/06/17 | 1,230 | 1,345 | 1,230 | 1,345 | +124 | +10.2% | 345,600 |
| 2024/06/14 | 1,139 | 1,247 | 1,129 | 1,221 | +22 | +1.8% | 433,100 |
| 2024/06/13 | 1,158 | 1,205 | 1,141 | 1,199 | +42 | +3.6% | 173,100 |
| 2024/06/12 | 1,171 | 1,193 | 1,157 | 1,157 | -52 | -4.3% | 258,300 |
| 2024/06/11 | 1,219 | 1,241 | 1,202 | 1,209 | -11 | -0.9% | 137,900 |
| 2024/06/10 | 1,225 | 1,225 | 1,196 | 1,220 | -3 | -0.2% | 130,800 |
| 2024/06/07 | 1,214 | 1,225 | 1,202 | 1,223 | -15 | -1.2% | 101,300 |
| 2024/06/06 | 1,276 | 1,276 | 1,238 | 1,238 | -36 | -2.8% | 107,700 |
| 2024/06/05 | 1,292 | 1,309 | 1,265 | 1,274 | -32 | -2.5% | 69,300 |
| 2024/06/04 | 1,288 | 1,322 | 1,288 | 1,306 | +18 | +1.4% | 45,000 |
| 2024/06/03 | 1,300 | 1,309 | 1,282 | 1,288 | +13 | +1% | 63,500 |
| 2024/05/31 | 1,269 | 1,284 | 1,259 | 1,275 | +13 | +1% | 57,700 |
| 2024/05/30 | 1,280 | 1,287 | 1,245 | 1,262 | -34 | -2.6% | 124,700 |
| 2024/05/29 | 1,353 | 1,353 | 1,294 | 1,296 | -66 | -4.8% | 122,600 |
| 2024/05/28 | 1,343 | 1,380 | 1,343 | 1,362 | +1 | +0.1% | 50,500 |
| 2024/05/27 | 1,330 | 1,363 | 1,330 | 1,361 | +31 | +2.3% | 50,600 |
| 2024/05/24 | 1,324 | 1,363 | 1,315 | 1,330 | -18 | -1.3% | 48,100 |
| 2024/05/23 | 1,333 | 1,354 | 1,323 | 1,348 | +16 | +1.2% | 56,800 |
| 2024/05/22 | 1,355 | 1,357 | 1,331 | 1,332 | -28 | -2.1% | 73,700 |
| 2024/05/21 | 1,405 | 1,405 | 1,351 | 1,360 | -59 | -4.2% | 116,500 |
| 2024/05/20 | 1,429 | 1,442 | 1,406 | 1,419 | -1 | -0.1% | 68,100 |
| 2024/05/17 | 1,399 | 1,421 | 1,382 | 1,420 | +16 | +1.1% | 74,700 |
| 2024/05/16 | 1,436 | 1,436 | 1,402 | 1,404 | -28 | -2% | 55,400 |
| 2024/05/15 | 1,490 | 1,490 | 1,432 | 1,432 | -59 | -4% | 57,800 |
| 2024/05/14 | 1,444 | 1,491 | 1,444 | 1,491 | +54 | +3.8% | 52,600 |
| 2024/05/13 | 1,416 | 1,447 | 1,416 | 1,437 | +15 | +1.1% | 59,200 |
| 2024/05/10 | 1,496 | 1,502 | 1,417 | 1,422 | -67 | -4.5% | 138,200 |
| 2024/05/09 | 1,528 | 1,536 | 1,481 | 1,489 | -13 | -0.9% | 87,300 |
| 2024/05/08 | 1,527 | 1,554 | 1,502 | 1,502 | -25 | -1.6% | 67,200 |
| 2024/05/07 | 1,520 | 1,547 | 1,514 | 1,527 | +16 | +1.1% | 56,400 |
| 2024/05/02 | 1,546 | 1,549 | 1,507 | 1,511 | -36 | -2.3% | 47,100 |
| 2024/05/01 | 1,568 | 1,568 | 1,502 | 1,547 | -12 | -0.8% | 88,000 |
| 2024/04/30 | 1,540 | 1,573 | 1,522 | 1,559 | +37 | +2.4% | 149,200 |
| 2024/04/26 | 1,509 | 1,556 | 1,497 | 1,522 | +5 | +0.3% | 216,300 |
| 2024/04/25 | 1,525 | 1,567 | 1,497 | 1,517 | -9 | -0.6% | 103,700 |
| 2024/04/24 | 1,536 | 1,549 | 1,513 | 1,526 | +6 | +0.4% | 61,000 |
| 2024/04/23 | 1,534 | 1,544 | 1,477 | 1,520 | +2 | +0.1% | 89,500 |
| 2024/04/22 | 1,497 | 1,523 | 1,478 | 1,518 | +51 | +3.5% | 111,900 |
| 2024/04/19 | 1,533 | 1,535 | 1,464 | 1,467 | -84 | -5.4% | 176,500 |
| 2024/04/18 | 1,467 | 1,572 | 1,467 | 1,551 | +98 | +6.7% | 172,400 |
| 2024/04/17 | 1,541 | 1,542 | 1,453 | 1,453 | -88 | -5.7% | 125,500 |
| 2024/04/16 | 1,550 | 1,595 | 1,535 | 1,541 | -5 | -0.3% | 198,800 |
| 2024/04/15 | 1,503 | 1,553 | 1,486 | 1,546 | +73 | +5% | 155,500 |
251～
300
件表示中 / 1389件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 67,200円 | - | - | 0.74% | 52.21倍 | 2.26倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| Ｃｈｏｒｄｉａ | 20,200円 | - | - | 0.00% | - | 4.30倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
| ステラファーマ | 39,500円 | +4.8% | - | 0.00% | - | 4.19倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
| ラクオリア | 52,700円 | +25.1% | - | 0.00% | - | 2.33倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
| キッズバイオ | 23,200円 | - | - | 0.00% | - | 8.26倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
